Total Payments
$65,274
2024 Payments
$2,677
Companies
35
Transactions
853
Medicare Patients
2,263
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$42,390 (64.9%)
Food & Beverage$15,820 (24.2%)
Travel$5,334 (8.2%)
Consulting$1,295 (2.0%)
Education$435.97 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,150 | 30 | 64.6% |
| Food and Beverage | $15,820 | 800 | 24.2% |
| Travel and Lodging | $5,334 | 13 | 8.2% |
| Consulting Fee | $1,295 | 1 | 2.0% |
| Education | $435.97 | 8 | 0.7% |
| Grant | $239.52 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $49,771 | 193 | $0 (2024) |
| Janssen Biotech, Inc. | $2,810 | 126 | $0 (2024) |
| ABBVIE INC. | $2,564 | 113 | $0 (2024) |
| UCB, Inc. | $1,720 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,501 | 67 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,370 | 2 | $0 (2022) |
| PFIZER INC. | $1,143 | 95 | $0 (2024) |
| Horizon Therapeutics plc | $809.17 | 55 | $0 (2023) |
| GlaxoSmithKline, LLC. | $556.12 | 29 | $0 (2024) |
| Genentech USA, Inc. | $508.77 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,677 | 99 | ABBVIE INC. ($1,009) |
| 2023 | $3,333 | 87 | Janssen Biotech, Inc. ($1,361) |
| 2022 | $4,246 | 96 | Amgen Inc. ($2,859) |
| 2021 | $6,745 | 109 | Amgen Inc. ($4,212) |
| 2020 | $6,388 | 40 | Amgen Inc. ($4,607) |
| 2019 | $7,939 | 73 | Amgen Inc. ($7,024) |
| 2018 | $21,776 | 189 | Amgen Inc. ($19,616) |
| 2017 | $12,170 | 160 | Amgen Inc. ($10,290) |
All Payment Transactions
853 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $123.50 | General |
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $129.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Immunology | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $54.37 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $20.56 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 492 | 19,084 | $794,241 | $285,917 |
| 2022 | 12 | 598 | 27,610 | $1.4M | $426,260 |
| 2021 | 10 | 575 | 10,516 | $889,091 | $199,861 |
| 2020 | 12 | 598 | 24,206 | $1.6M | $449,520 |
Total Patients
2,263
Total Services
81,416
Medicare Billing
$1.4M
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 26 | 14,600 | $408,100 | $153,015 | 37.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 30 | 3,240 | $147,300 | $60,018 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 256 | 487 | $131,635 | $43,484 | 33.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 41 | 209 | $72,105 | $20,536 | 28.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 38 | 69 | $13,450 | $3,721 | 27.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 30 | 54 | $10,206 | $3,130 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 30 | $5,520 | $1,978 | 35.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 43 | 395 | $5,925 | $34.17 | 0.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 5,150 | $479,225 | $177,943 | 37.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 16 | 10,300 | $513,850 | $118,027 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 540 | $145,800 | $47,938 | 32.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 30 | 2,700 | $92,220 | $45,147 | 49.0% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2022 | 11 | 7,896 | $23,688 | $11,633 | 49.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 23 | 61 | $23,850 | $6,929 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 85 | $15,640 | $5,859 | 37.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 54 | 115 | $22,838 | $5,794 | 25.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 28 | 97 | $23,325 | $5,398 | 23.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 13 | 13 | $2,457 | $817.44 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 27 | 64 | $4,303 | $724.08 | 16.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 63 | 589 | $8,835 | $48.42 | 0.5% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2021 | 11 | 6,700 | $566,150 | $91,598 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 280 | 544 | $146,880 | $50,002 | 34.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 27 | 2,340 | $100,620 | $38,102 | 37.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 22 | 98 | $20,580 | $5,909 | 28.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 84 | $15,456 | $5,878 | 38.0% |
About Dr. John Tower, DO
Dr. John Tower, DO is a Rheumatology healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558329359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tower, DO has received a total of $65,274 in payments from pharmaceutical and medical device companies, with $2,677 received in 2024. These payments were reported across 853 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,150).
As a Medicare-enrolled provider, Tower has provided services to 2,263 Medicare beneficiaries, totaling 81,416 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Rochester Hills, MI
- Active Since 05/02/2006
- Last Updated 12/03/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1558329359
Products in Payments
- Enbrel (Biological) $43,401
- RINVOQ (Biological) $1,468
- SIMPONI ARIA (Biological) $1,228
- TREMFYA (Drug) $1,222
- COSENTYX (Biological) $1,191
- XELJANZ (Drug) $1,030
- KRYSTEXXA (Biological) $631.16
- RAYOS (Drug) $559.81
- BENLYSTA (Biological) $556.12
- Humira (Biological) $496.66
- ORENCIA (Biological) $395.80
- Actemra (Biological) $355.69
- TAVNEOS (Drug) $339.13
- TALTZ (Drug) $339.10
- REMICADE (Biological) $307.77
- Cimzia (Drug) $300.44
- STELARA (Biological) $286.25
- Otezla (Drug) $243.78
- Zilretta (Drug) $230.87
- COSENTYX (Drug) $206.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Rochester Hills
Dr. Roman Czubatyj, M.d, M.D
Rheumatology — Payments: $701,894
Rheumatology $701,894
Dr. Patricia Cagnoli, M.d, M.D
Rheumatology — Payments: $94,947
Rheumatology $94,947
Dr. Josephine Aloot, Md, MD
Rheumatology — Payments: $16,632
Rheumatology $16,632
Dr. Phyllis Birkel, Md, MD
Rheumatology — Payments: $16,441
Rheumatology $16,441
Dr. Dana Rockwell, D.o, D.O
Rheumatology — Payments: $12,917
Rheumatology $12,917